Hepatitis C remains one of the most commonly reported blood-borne infections in the United States and continues to cause significant morbidity and mortality when undiagnosed or untreated. Nationally, hepatitis C infection disproportionately affects individuals in correctional settings, with a rate approximately 10 times higher as compared to the general population[1]. The New York State Hepatitis […]
Tag Archives: Blog
30
Jul
Jul
People who use drugs (PWUD) are at the highest risk for acquiring hepatitis C. The New York State (NYS) Hepatitis C Elimination plan has identified PWUD as the priority population for elimination. New treatments available to cure hepatitis C should be made accessible to PWUD. Guidelines support treating PWUD, even those actively using. As shown […]
07
May
May
Newly released hepatitis C (HCV) elimination metrics show that in 2024, 4,323 people were newly diagnosed with HCV in New York State (NYS), a 9.7% decrease from 2023 and a 75.7% decrease overall since 2014. From 2010 to 2024, 203,442 New Yorkers were diagnosed with HCV, of which 55.9% are known to have cleared their […]
21
Jan
Jan
Click to view full page flyer Sign up here
29
Oct
Oct
In June of 2024, the United States (US) Food and Drug Administration (FDA) approved Cepheid’s GeneXpert (XpertⓇHCV) for Point of Care (POC) hepatitis C (HCV) diagnostic testing, the first of its kind for HCV in the US. The test is CLIA (Clinical Laboratory Improvement Amendment) waived, meaning the instrument is simple to use and with […]
06
Jun
Jun
On May 15, 2024, New York State hosted the second Annual Hepatitis C Elimination Progress Report virtual meeting to share progress toward reaching its elimination goals, as outlined in the 2021 release of the New York State Hepatitis C Elimination Plan. All of the materials and presentations from the May meeting are now available: Hepatitis […]
Announcements
Newly Released 2022 New York State Hepatitis C Elimination Metrics Data is Now Available
15
May
May
In 2022 there were 5,169 people newly diagnosed with hepatitis C (HCV) in New York State (NYS), a 9% decrease from 2021, continuing the downward trend of HCV diagnoses over the previous decade. Between 2010 and 2022, 194,375 New Yorkers were diagnosed with HCV, and of those, 53% are known to have cleared their infection […]
15
Feb
Feb
NYS Test4HepC Campaign to Promote Hepatitis C Screening During Pregnancy Universal hepatitis C screening among pregnant people was identified in the New York State Hepatitis C Elimination Plan as a priority for moving the state towards hepatitis C elimination by 2030. Effective May 3, 2024, New York State’s hepatitis C testing legislation will require all […]
Announcements
Increasing Capacity to Provide Hepatitis C Virus (HCV) Testing in Substance Use Disorder Treatment Programs
19
Jan
Jan
What is the Learning Collaborative? The New York State Hepatitis C Learning Collaborative for Substance Use Disorder Treatment Programs is a two-year initiative to help programs build capacity to provide onsite HCV testing and linkage to care. The New York State Department of Health (NYSDOH) launched the first cycle of the learning collaborative on April […]
- 1
- 2